Computed Tomography Scanning in ICU

Sponsor
Meir Medical Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06033235
Collaborator
(none)
1,000
1
24
41.6

Study Details

Study Description

Brief Summary

Patients admitted to the intensive care unit often require CT imaging. Performing this diagnostic test on a critically ill patient involves risks, such as those associated with transferring a ventilated and unstable patient and those associated with the injection of intravenous contrast material. Also, multiple CT examinations may create a burden on the X-ray institute and the medical staff, result in the postponement of CT examinations for other patients, as well as increase hospitalization costs.

In this work, we would like to check the rate of complications involved in performing a CT scan in patients hospitalized in the general intensive care unit of our institution, while analyzing the differences between the times the test is performed (morning, night shift), as well as examine in what percentage of the CT scans the test performed contributed to a significant progress in the diagnosis or a significant change in the treatment plan of the patient, while referring to subgroups (sepsis, trauma, respiratory failure, with an emphasis on covid patients, patients with scoliosis, patients with intracranial pathology).

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: CT scan in critically ill patients in the intensive care unit

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Impact of Computed Tomography Scanning on ICU Patient Management: Retrospective Study
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2025
Anticipated Study Completion Date :
Nov 1, 2025

Outcome Measures

Primary Outcome Measures

  1. Change in diagnosis and/or patient management [3 years]

    To examine in what percentage of the CT examinations the examination contributed to a significant progress in the diagnosis or a significant change in the patient's treatment plan, while referring to subgroups of patients in the intensive care unit.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria:All patients who underwent CT examinations during hospitalization in the intensive care unit for any etiology, from January 2020 to January 2023.

-

Exclusion Criteria:Patients who did not meet the above criteria or for whom data were missing.

-

Contacts and Locations

Locations

Site City State Country Postal Code
1 Meir Medical Center Kfar Saba Israel

Sponsors and Collaborators

  • Meir Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
sara dichtwald, Dr, Meir Medical Center
ClinicalTrials.gov Identifier:
NCT06033235
Other Study ID Numbers:
  • 0220-23-MMC
First Posted:
Sep 13, 2023
Last Update Posted:
Sep 13, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 13, 2023